000170012 001__ 170012
000170012 005__ 20240229133703.0
000170012 0247_ $$2doi$$a10.1007/s00066-021-01823-z
000170012 0247_ $$2pmid$$apmid:34312699
000170012 0247_ $$2ISSN$$a0179-7158
000170012 0247_ $$2ISSN$$a1439-099X
000170012 0247_ $$2altmetric$$aaltmetric:110637435
000170012 037__ $$aDKFZ-2021-01706
000170012 041__ $$aGerman
000170012 082__ $$a610
000170012 1001_ $$0P:(DE-He78)80e100a16534f5fc67f7436ee67a47f9$$aRühle, Alexander$$b0$$eFirst author
000170012 245__ $$aModerate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : Results of the NRG-HN002 trial[Moderate Dosisdeeskalation der definitiven Cisplatin-basierten Radiochemotherapie für HPV-positive Oropharynxkarzinompatienten : Ergebnisse der NRG-HN002-Studie].
000170012 260__ $$aHeidelberg$$bSpringer Medizin$$c2021
000170012 3367_ $$2DRIVER$$aarticle
000170012 3367_ $$2DataCite$$aOutput Types/Journal article
000170012 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1675085630_23510
000170012 3367_ $$2BibTeX$$aARTICLE
000170012 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000170012 3367_ $$00$$2EndNote$$aJournal Article
000170012 500__ $$a2021 Oct;197(10):950-952 / #EA:E055#LA:E055#
000170012 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000170012 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000170012 7001_ $$0P:(DE-He78)8d52e7ff1ccaac7dbf0232fdcb0168bd$$aNicolay, Nils H$$b1$$eLast author
000170012 773__ $$0PERI:(DE-600)2003907-4$$a10.1007/s00066-021-01823-z$$gp. s00066-021-01823-z$$n10$$p950-952$$tStrahlentherapie und Onkologie$$v197$$x1439-099X$$y2021
000170012 909CO $$ooai:inrepo02.dkfz.de:170012$$pVDB
000170012 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)80e100a16534f5fc67f7436ee67a47f9$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000170012 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d52e7ff1ccaac7dbf0232fdcb0168bd$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000170012 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000170012 9141_ $$y2021
000170012 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-26$$wger
000170012 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-01-26$$wger
000170012 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSTRAHLENTHER ONKOL : 2019$$d2021-01-26
000170012 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-26
000170012 9202_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x0
000170012 9201_ $$0I:(DE-He78)FR01-20160331$$kFR01$$lDKTK FR zentral$$x0
000170012 9201_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x1
000170012 9200_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x0
000170012 980__ $$ajournal
000170012 980__ $$aVDB
000170012 980__ $$aI:(DE-He78)FR01-20160331
000170012 980__ $$aI:(DE-He78)E055-20160331
000170012 980__ $$aUNRESTRICTED